Aiming T-cell engagers at autoimmune diseases continues to be a red-hot dealmaking target, as evidenced by Otsuka Pharmaceutical’s decision to pay $47 million upfront for the ex-China rights to ...

Conducted in collaboration with Professor Huji Xu’s clinical team at Shanghai Changzheng Hospital, this work marks the first-ever application of iPSC-CAR-NK cells in treating autoimmune disease ...

Findings reveal an intricate mechanism that enables a careful treatment approach to T-cell driven autoimmune diseases.

Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the United States alone, it disrupts the lives of about 1.

A new article published in Nature offers a promising path toward a shorter, more effective treatment for tuberculosis (TB), a bacterial disease that affects millions worldwide.

Conducted in collaboration with Professor Huji Xu’s clinical team at Shanghai Changzheng Hospital, this work marks the first-ever application of iPSC-CAR-NK cells in treating autoimmune disease ...

Cue Biopharma receives positive FDA feedback on CUE-401, a novel T cell modulator for autoimmune disease treatment.

Prednisone alone or a lower dose in combination with azathioprine is the mainstay treatment for all forms of autoimmune hepatitis.

Medically reviewed by Danielle Weiss, MD Type 2 diabetes is not an autoimmune condition, while type 1 diabetes is. Though new research suggests the immune system may be involved in type 2 diabetes ...

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type-1 diabetes, hepatitis, multiple sclerosis, shows a new study in mice.